Thiazolidinedione-induced fluid retention is independent of collecting duct αENaC activity

Journal of the American Society of Nephrology

Volumn 20, Issue 4, 2009, Pages 721-729

  Vallon, Volker ^a,b,c,g   Hummler, Edith ^d   Rieg, Timo ^a,b,c   Pochynyuk, Oleh ^e   Bugaj, Vladislav ^e   Schroth, Jana ^a,b,c   Dechenes, Georges ^f   Rossier, Bernard ^d   Cunard, Robyn ^a,b,c   Stockand, James ^e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c San Diego   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Mays Cancer Center at UT Health San Antonio   (United States)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALDOSTERONE; EPITHELIAL SODIUM CHANNEL; LITHIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

ABDOMINAL FAT; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIURESIS; FEMALE; FLUID RETENTION; GENE INACTIVATION; HEMATOCRIT; KIDNEY COLLECTING TUBULE; MALE; MOUSE; NONHUMAN; PATCH CLAMP; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM TRANSPORT; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING; WILD TYPE;

EID: 65249106033     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008040415     Document Type: Article

References (49)

1. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645650, 1990
2. Sharma AM, Staels B: Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-Understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92: 386-395, 2007
3. Marx N, Duez H, Fruchart JC, Staels B: Peroxisome proliferator-acti- vated receptors and atherogenesis: Regulators of gene expression in vascular cells. Circ Res 94: 1168-1178, 2004
4. Duan SZ, Usher MG, Mortensen RM: Peroxisome proliferator-acti- vated receptor-gamma-mediated effects in the vasculature. Circ Res 102: 283-294, 2008
5. Kapadia R, Yi JH, Vemuganti R: Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13: 1813-1826, 2008
6. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R: Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation 108: 29412948, 2003
7. Vasudevan AR Balasubramanyam A: Thiazolidinediones: A review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther 6: 850-863, 2004
8. Niemeyer NV, Janney LM: Thiazolidinedione-induced edema. Phar- macotherapy 22: 924-929, 2002
9. Sotiropoulos KB, Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, Della VK, Kondo T, Aiello LP, King GL: Adipose- specific effect of rosiglitazone on vascular permeability and protein kinase C activation: Novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J 20: 1203-1205, 2006
10. Emoto M, Anno T, Sato Y, Tanabe K, Okuya S, Tanizawa Y, Matsutani A, Oka Y: Troglitazone treatment increases plasma vascular endothe- lial growth factor in diabetic patients and its mRNA in 3T3-L1 adipo- cytes. Diabetes 50: 1166-1170, 2001
11. Gardiner SM, Nunez DJ, Baer PG, Brown KK, Bennett T: Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2- (2-benzoylphenylamino)-3-[4-[2-(5- methyl-2-phenyl-2-oxazol-4-yl)eth oxy]phenyl]propionic acid], in conscious rats. J Pharmacol Exp Ther 310: 1226-1233, 2004
12. Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med 134: 61-71, 2001
13. Buchanan TA, Meehan WP, Jeng YY, Yang D, Chan TM, Nadler JL, Scott S, Rude RK, Hsueh WA: Blood pressure lowering by pioglitazone: Evidence for a direct vascular effect. J Clin Invest 96: 354-360, 1995
14. Yang B, Clifton LG, McNulty JA, Chen L, Brown KK, Baer PG: Effects of a PPARgamma agonist, GI262570, on renal filtration fraction and nitric oxide level in conscious rats J Cardiovasc Pharmacol 42: 436441, 2003
15. Song J, Knepper MA, Hu XQ, Verbalis JG, Ecelbarger CA: Rosiglita- zone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. J Pharmacol Exp Ther 308: 426-433, 2004
16. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T: Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci USA 102: 9406-9411, 2005
17. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD: Thiazolidinediones expand body fluid volume through PPARgamma stimulation ofENaC-mediated renal salt absorption. Nat Med 11: 861-866, 2005
18. Chen L, Yang B, McNulty JA, Clifton LG, Binz JG, Grimes AM, Strum JC, Harrington WW, Chen Z, Balon TW, Stimpson SA, Brown KK: GI262570, a peroxisome proliferator-activated receptor gamma agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther 312: 718-725, 2005
19. Staels B: Fluid retention mediated by renal PPAR gamma. Cell Metab 2: 77-78, 2005
20. Rubera I, Loffing J, Palmer LG, Frindt G, Fowler-Jaeger N, Sauter D, Carroll T, McMahon A, Hummler E, Rossier BC: Collecting duct- specific gene inactivation ofalphaENaC in the mouse kidneydoes not impair sodium and potassium balance. J Clin Invest 112: 554 -565, 2003
21. Hummler E, Merillat AM, Rubera I, Rossier BC, Beermann F: Conditional gene targeting of the Scnn1a (alphaENaC) gene locus. Genesis 32: 169-172, 2002
22. Frindt G, Palmer LG: Na channels in the rat connecting tubule. Am J Physiol Renal Physiol 286: F669-F674, 2004
23. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA: The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A 95: 14552-14557, 1998
24. Loffing J, Vallon V, Loffing-Cueni D, Aregger F, Richter K, Pietri L, Bloch-Faure M, Hoenderop JG, Shull GE, Meneton P, Kaissling B: Altered renal distal tubule structure and renal Na(+) and Ca(2+) handling in a mouse model for Gitelman's syndrome. J Am Soc Nephrol 15: 2276-2288, 2004
25. Meneton P, Loffing J, Warnock DG: Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule. Am J Physiol Renal Physiol 287: F593- F601, 2004
26. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S: Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95: 1838-1845, 1995
27. Christensen BM, Loffing J, Hummler E, Rossier B: Collecting duct- specific gene inactivation of alpha ENaC protects mice against lithium-induced nephrogenic diabetes insipidus [Abstract]. J Am Soc Nephrol 17: 295A, 2006
28. Kemendy AE, Kleyman TR, Eaton DC: Aldosterone alters the open probability of amiloride-blockable sodium channels in A6 epithelia. Am J Physiol 263: C825-C837, 1992
29. Palmer LG, Li JH, Lindemann B, Edelman IS: Aldosterone control of the density of sodium channels in the toad urinary bladder. J Membr Biol 64: 91-102, 1982
30. Frindt G, Sackin H, Palmer LG: Whole-cell currents in rat cortical collecting tubule: Low-Na diet increases amiloride-sensitive conductance. Am J Physiol 258: F562-F567, 1990
31. Pacha J, Frindt G, Antonian L, Silver RB, Palmer LG: Regulation of Na channels of the rat cortical collecting tubule by aldosterone. J Gen Physiol 102: 25-42, 1993
32. Light DB, Schwiebert EM, Karlson KH, Stanton BA: Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243: 383-385, 1989
33. Ono S, Mougouris T, DuBose TD Jr, Sansom SC: ATP and calcium modulation of nonselective cation channels in IMCD cells. Am J Physiol 267: F558-F565, 1994
34. Nofziger C, Chen L, Shane MA, Smith CD, Brown KK, Blazer-Yost BL: PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel. Pflugers Arch 451: 445-453, 2005
35. Zanchi A, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M: Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab 89: 1140-1145, 2004
36. Light DB, McCann FV, Keller TM, Stanton BA: Amiloride-sensitive cation channel in apical membrane of inner medullary collecting duct. Am J Physiol 255: F278-F286, 1988
37. Light DB, Ausiello DA, Stanton BA: Guanine nucleotide-binding protein, alpha i-3, directly activates a cation channel in rat renal inner medullary collecting duct cells. J Clin Invest 84: 352-356, 1989
38. Rieg T, Pothula K, Schroth J, Satriano J, Osswald H, Schnermann J, Insel PA, Bundey RA, Vallon V: Vasopressin regulation of inner medullary collecting ducts and compensatory changes in mice lacking adenosine A1 receptors. Am J Physiol Renal Physiol 294: F638-F644, 2008
39. Rieg T, Bundey RA, Chen Y, Deschenes G, Junger W, Insel PA, Vallon V: Mice lacking P2Y2 receptors have salt-resistant hypertension and facilitated renal Na+ and water reabsorption. FASEB J 21: 3717-3726, 2007
40. Lourdel S, Loffing J, Favre G, Paulais M, Nissant A, Fakitsas P, Cremi- non C, Feraille E, Verrey F, Teulon J, Doucet A, Deschenes G: Hyper- aldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis. J Am Soc Nephrol 16: 3642-3650, 2005
41. Ergonul Z, Frindt G, Palmer LG: Regulation of maturation and processing of ENaC subunits in the rat kidney. Am J Physiol Renal Physiol 291: F683-F693, 2006
42. Vallon V, Grahammer F, Volkl H, Sandu CD, Richter K, Rexhepaj R, Gerlach U, Rong Q, Pfeifer K, Lang F: KCNQ1-dependent transport in renal and gastrointestinal epithelia. Proc Natl Acad Sci U S A 102: 17864-17869, 2005
43. Staruschenko A, Pochynyuk O, Vandewalle A, Bugaj V, Stockand JD: Acute regulation of the epithelial Na+ channel by phosphatidylinosit- ide 3-OH kinase signaling in native collecting duct principal cells. J Am Soc Nephrol 18: 1652-1661, 2007
44. Husted RF, Matsushita K, Stokes JB: Induction of resistance to miner- alocorticoid hormone in cultured inner medullary collecting duct cells by TGF-beta 1. Am J Physiol 267: F767-F775, 1994
45. Babilonia E, Li D, Wang Z, Sun P, Lin DH, Jin Y, Wang WH: Mitogen- activated protein kinases inhibit the ROMK (Kir 1.1)-like small conductance K channels in the cortical collecting duct. J Am Soc Nephrol 17: 2687-2696, 2006
46. Li D, Wei Y, Babilonia E, Wang Z, Wang WH: Inhibition of phos- phatidylinositol 3-kinase stimulates activity of the small-conductance K channel in the CCD. Am J Physiol Renal Physiol 290: F806-F812, 2006
47. Sun P, Lin DH, Wang T, Babilonia E, Wang Z, Jin Y, Kemp R, Nasjletti A, Wang WH: Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC. Am J Physiol Renal Physiol 291: F1192-F1200, 2006
48. Pochynyuk O, Bugaj V, Vandewalle A, Stockand JD: Purinergic control of apical plasma membrane PI(4,5)P2 levels sets ENaC activity in principal cells. Am J Physiol Renal Physiol 294: F38-F46, 2008
49. Pochynyuk O, Tong Q, Medina J, Vandewalle A, Staruschenko A, Bugaj V, Stockand JD: Molecular determinants of PI(4,5)P2 and PI(3,4,5)P3 regulation of the epithelial Na+ channel. J Gen Physiol 130: 399-413, 2007